2021
|
Invention
|
Long acting glucagon like polypeptide-1 (glp-1) receptor agonists and methods of use. i.e1/21/2),... |
|
Invention
|
Use of human amylin analog polypeptides for providing superior glycemic control to type 1 diabeti... |
|
Invention
|
Long acting peptide tyrosine tyrosine (pyy) analogs and methods of use. 1/2), and improved solubi... |
|
Invention
|
Long acting peptide tyrosine tyrosine (pyy) analogs and methods of use. i.e1/21/2), and improved ... |
|
Invention
|
Long acting glucagon receptor selective peptides and methods of use. i.e1/21/2), and improved sol... |
2020
|
Invention
|
Methods comprising continuous administration of exenatide and co-administration of a drug. Provid... |
|
Invention
|
Therapeutic methods for the treatment of diabetes and related conditions for patients with high b... |
2019
|
Invention
|
Glucagon-receptor selective polypeptides and methods of use thereof. This invention relates to is... |
|
Invention
|
Human amylin analog polypeptides and methods of use. This invention relates to isolated polypepti... |
|
Invention
|
Implant removal tool |
|
Invention
|
Suspension formulation comprising an insulinotropic peptide. A suspension formulation of an insul... |
2018
|
Invention
|
Implant placement guide |
|
Invention
|
Implant removal tool and assembly |
|
Invention
|
Rapid establishment and/or termination of substantial steady-state drug delivery. The present inv... |
|
Invention
|
Devices, formulations, and methods for delivery of multiple beneficial agents. The present invent... |
|
Invention
|
Apparatus and methods for administration of a nauseogenic compound from a drug delivery device.
... |
|
Invention
|
Apparatus and methods for administration of a nauseogenic compound from a drug delivery device. P... |
|
Invention
|
Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of ... |
|
Invention
|
Methods comprising continuous administration of a glp-1 receptor agonist and co-administration of... |
2017
|
Invention
|
Methods of manufacturing viscous liquid pharmaceutical formulations.
A liquid composition in an ... |
|
Invention
|
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles.
This ... |
|
Invention
|
Solvent/polymer solutions as suspension vehicles.
A nonaqueous, single-phase vehicle that is cap... |
|
Invention
|
Method of manufacturing an osmotic delivery device. A suspension formulation of an insulinotropic... |
|
Invention
|
Compositions, devices and methods of use thereof for the treatment of cancers. The use of GLP-1 r... |
|
Invention
|
Glucagon receptor/glp-1 receptor selective analog polypeptides and methods of use thereof. This i... |
|
G/S
|
Pharmaceutical preparations for the treatment of diabetes, obesity and metabolic diseases/disorde... |
|
G/S
|
Pharmaceutical preparations for the treatment of diabetes, obesity and metabolic diseases and dis... |
|
G/S
|
Scientific, pharmaceutical and medical research and development services; Research design and tes... |
|
Invention
|
Highly concentrated drug particles, formulations, suspensions and uses thereof.
Highly concentra... |
2016
|
G/S
|
Pharmaceutical hormonal preparations, namely, hormone analogues for the treatment of diabetes, ob... |
|
Invention
|
Devices, formulations, and methods for delivery of multiple beneficial agents.
The present inven... |
|
G/S
|
An implantable subdermal drug delivery device filled with a pharmaceutical preparation formulated... |
|
Invention
|
Two-piece, internal-channel osmotic delivery system flow modulator.
An osmotic delivery system f... |
|
Invention
|
Osmotic delivery device comprising an insulinotropic peptide and uses thereof. A suspension formu... |
|
Invention
|
Implant placement and removal systems. Devices, methods, and systems are provided for placing an ... |
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations for the treatment of diabetes, obesity a... |
2015
|
G/S
|
Pharmaceutical preparations; drug delivery devices filled with pharmaceutical preparations; drug ... |
|
Invention
|
Solvent/polymer solutions as suspension vehicles. A nonaqueous, single-phase vehicle that is capa... |
|
Invention
|
Osmotic delivery device comprising an insulinotropic peptide and uses thereof.
A suspension form... |
2014
|
G/S
|
Pharmaceutical preparations; drug delivery devices filled with pharmaceutical preparations; pharm... |
2010
|
G/S
|
Pharmaceutical preparations; drug delivery devices filled with pharmaceutical preparations. Drug ... |
2008
|
G/S
|
Antivirals. |
|
G/S
|
Drug delivery system consisting of an osmotic mini-pump sold with medication used in the continuo... |
|
G/S
|
Pharmaceutical preparations. Drug delivery devices. Scientific and medical research and developme... |
2004
|
G/S
|
Pharmaceutical preparations. Printed materials and instructional matter related to the field of p... |